Join
Live feed
·
INSIDERFilingvia Quantisnow
Lineage Cell Therapeutics Inc. logo

General Counsel and Secretary Samuel George A. Iii was granted 1,735 shares and covered exercise/tax liability with 65 shares, increasing direct ownership by 6% to 27,490 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
LCTX· Lineage Cell Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LCTX (Lineage Cell Therapeutics Inc.) and more on Quantisnow.